Noemi Esteras

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

NRF2 at the crossroads of Parkinson's disease and aging: Mechanistic insights and translational perspectives.

NRF2 at the crossroads of Parkinson's disease and aging: Mechanistic insights and translational perspectives.

Journal: Free radical biology & medicine

Published: December 17, 2025

Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicity.

Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 05, 2025

Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases.

Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases.

Journal: Antioxidants (Basel, Switzerland)

Published: August 06, 2025

α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons.

α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons.

Journal: Redox biology

Published: July 14, 2025

Multitarget Effects of Nrf2 Signalling in the Brain: Common and Specific Functions in Different Cell Types.

Multitarget Effects of Nrf2 Signalling in the Brain: Common and Specific Functions in Different Cell Types.

Journal: Antioxidants (Basel, Switzerland)

Published: November 20, 2024

Charcot Marie Tooth disease pathology is associated with mitochondrial dysfunction and lower glutathione production.

Charcot Marie Tooth disease pathology is associated with mitochondrial dysfunction and lower glutathione production.

Journal: Cellular and molecular life sciences : CMLS

Published: October 07, 2024

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality and disrupt mitochondrial function.

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality and disrupt mitochondrial function.

Journal: medRxiv : the preprint server for health sciences

Published: August 16, 2024

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Journal: Nature communications

Published: July 14, 2024

A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function.

A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function.

Journal: The FEBS journal

Published: April 08, 2024

Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson's Disease.

Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson's Disease.

Journal: Molecular neurobiology

Published: September 29, 2023

KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy.

KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy.

Journal: Scientific reports

Published: August 07, 2023

Nrf2 regulates glucose uptake and metabolism in neurons and astrocytes.

Nrf2 regulates glucose uptake and metabolism in neurons and astrocytes.

Journal: Redox biology

Published: January 11, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026